TBK1/ULK1 Axis Links Lysosomal Stress to TFEB Activation

A research team has identified a critical signaling axis involving the kinases TBK1 and ULK1 that directly links lysosomal stress to the activation of TFEB (Transcription Factor EB) on September 30, 2026. This discovery, published in Nature, elucidates a previously unknown regulatory mechanism for cellular adaptation to stress and has implications for understanding tumorigenesis. The study utilized proteomic and phosphoproteomic analyses focused on lysosomes to uncover this nutrient-independent regulatory arm of mTORC1 signaling. This pathway plays a vital role in mediating lysosomal adaptation in response to various cellular stresses.

Lysosomes are essential organelles responsible for degrading waste materials and cellular debris. When lysosomes experience stress, such as damage or overload, cellular signaling pathways are activated to restore their function and maintain cellular homeostasis. The newly identified TBK1/ULK1 signaling axis acts as a crucial intermediary, translating the signal of lysosomal stress into the activation of TFEB. TFEB is a master transcriptional regulator that controls the expression of genes involved in lysosomal biogenesis, autophagy, and lysosomal enzyme production. By activating TFEB, the cell initiates a coordinated response to clear damaged lysosomes, enhance autophagic flux, and replenish lysosomal components.

The research highlights that this regulatory mechanism is nutrient-independent, meaning it functions even when nutrient levels are sufficient, suggesting a dedicated stress-response pathway. Deregulation of this TBK1/ULK1-TFEB axis was found to underlie tumorigenesis, specifically in follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin lymphoma that arises from B cells in the lymph nodes. Aberrant lysosomal function and impaired cellular stress responses are known contributors to cancer development, and this study provides a specific molecular mechanism for how such dysregulation can lead to uncontrolled cell proliferation and tumor formation.

This finding expands our understanding of lysosomal biology and cellular stress responses. It offers potential new therapeutic targets for diseases characterized by lysosomal dysfunction or impaired stress adaptation, including certain types of cancer and neurodegenerative disorders. Further research into the precise molecular interactions within the TBK1/ULK1-TFEB pathway could pave the way for novel treatment strategies aimed at restoring lysosomal health and preventing disease progression. The study's publication in Nature underscores its significance and the robust nature of the experimental evidence presented.